Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FHTX
#3392
Foghorn Therapeutics Inc. Common Stock
4.865
0
USD
+3.73%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.73%
Monthly Change
-1.12%
6 month change
+19.24%
Year Change
+19.24%
Previous Close
4.690
0
Open
4.865
0
Bid
Ask
Low
4.865
0
High
4.865
0
Volume
1
Markets
US Stock Market
Healthcare
FHTX
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
36.82 M
41.42 M
41.8 M
42.57 M
55.61 M
58.7 M
—
Valuation ratios
Enterprise value
735.48 M
904.52 M
219.51 M
194.21 M
207.04 M
236.11 M
758.86 M
Price to earnings ratio
—
-8.38
-2.48
-2.76
-2.99
-4.58
-16.22
Price to sales ratio
—
644.51
14.06
7.93
11.46
11
44.37
Price to cash flow ratio
—
-16.92
1.4
-2.29
-2.58
-3.95
-12.64
Price to book ratio
—
8.78
2 413.79
-3.51
-5.69
-3.13
-7.02
Enterprise value to EBITDA ratio
-9.72
-8.68
-1.93
-1.86
-2.08
-2.84
-8.78
Profitability ratios
Return on assets %
-0.27
-0.19
-0.27
-0.34
-0.31
-0.37
-0.34
Return on equity %
-0.47
-1.05
-972.16
1.28
1.9
0.68
0.92
Return on invested capital %
-182.8
-101.55
-88.31
-171.33
-202.12
-217.46
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-15.94 K
-7 637.15
-609.2
-315.93
-454.31
-279.49
-1 149.28
EBITDA margin %
-15.63 K
-7 392.49
-591.93
-305.83
-440.51
-268.71
-1 104.81
Net margin %
-16 K
-7 681.58
-566.27
-288.17
-383.24
-240.33
-982.45
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
10.12
9.44
6.37
4.11
3.73
2.73
10.68
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0.04
0.1
0.08
0.13
0.14
Solvency ratios
Debt to assets ratio
0.32
0.11
—
—
—
—
—
Debt to equity ratio
0.56
0.6
—
—
—
—
—
Long term debt to total assets ratio
0.08
0
—
—
—
—
—
Long term debt to total equity ratio
0.13
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-1.35
4.66
-2.81
-1.83
-1.37
-1.37
EBIT per share
—
-2.71
-2.82
-2.57
-1.87
-1.37
-1.37
EBITDA per share
—
-2.62
-2.74
-2.49
-1.81
-1.32
-1.32
Total debt per share
—
1.57
—
—
—
—
—
Cash per share
—
2.72
1.26
1.91
1.01
1.28
4.82
Net current asset value per share
—
12.36
8.45
5.72
4.55
2.59
12.34
Tangible book value per share
—
2.61
0
-1.84
-0.83
-1.72
-5.34
Working capital per share
—
11.05
7.12
4.33
3.33
1.64
7.67
Book value per share
—
2.61
0
-1.84
-0.83
-1.72
-5.34
News
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?
Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress
Jefferies reiterates Foghorn Therapeutics stock rating on pipeline data
Stifel reiterates Foghorn Therapeutics stock rating at buy
Foghorn earnings missed by $0.02, revenue fell short of estimates
Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates
Foghorn Therapeutics reports $158.9M cash position, extends runway
Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates
Foghorn Therapeutics names Ryan Maynard as chief financial officer
Jefferies initiates Foghorn Therapeutics stock with buy rating
Top Healthcare Stocks for This Year According to BTIG
Foghorn Therapeutics stock reaffirmed as Buy by BTIG, named top pick for 1H26